Veradigm Inc
OTC:MDRX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Veradigm Inc
Other Current Assets
Veradigm Inc
Other Current Assets Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other Current Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
Veradigm Inc
OTC:MDRX
|
Other Current Assets
$57.3m
|
CAGR 3-Years
-28%
|
CAGR 5-Years
-25%
|
CAGR 10-Years
-10%
|
|
|
Veeva Systems Inc
NYSE:VEEV
|
Other Current Assets
$126.5m
|
CAGR 3-Years
16%
|
CAGR 5-Years
29%
|
CAGR 10-Years
29%
|
|
|
Inspire Medical Systems Inc
NYSE:INSP
|
Other Current Assets
$10.4m
|
CAGR 3-Years
24%
|
CAGR 5-Years
39%
|
CAGR 10-Years
N/A
|
|
|
Doximity Inc
NYSE:DOCS
|
Other Current Assets
$37.1m
|
CAGR 3-Years
14%
|
CAGR 5-Years
29%
|
CAGR 10-Years
N/A
|
|
|
Omnicell Inc
NASDAQ:OMCL
|
Other Current Assets
$151.1m
|
CAGR 3-Years
18%
|
CAGR 5-Years
22%
|
CAGR 10-Years
19%
|
|
|
W
|
Waystar Holding Corp
NASDAQ:WAY
|
Other Current Assets
$38.7m
|
CAGR 3-Years
-3%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Veradigm Inc
Glance View
Veradigm Inc., formerly known as Allscripts Healthcare Solutions, has carved out a distinct niche within the healthcare technology landscape. The company focuses on the dynamic intersection of technology and healthcare, developing an array of solutions aimed at enhancing healthcare delivery and efficiency. Essentially, Veradigm equips medical professionals with tools for electronic health records, practice management, and remote patient monitoring. By leveraging sophisticated information systems, Veradigm helps streamline operations in doctor's offices, hospitals, and healthcare organizations, making it easier for healthcare providers to deliver efficient and effective services. Their products are designed not only to improve clinical workflows but also to enhance patient engagement, ultimately leading to better health outcomes. The revenue model of Veradigm hinges largely on contractual agreements and subscriptions for its software solutions. By offering a range of cloud-based services, the company ensures a steady flow of recurrent income while reducing the need for expensive on-site installations, thus delivering value to both large hospital systems and smaller, private practices. Additionally, Veradigm has diversified its revenue streams through collaborations with pharmaceutical companies, providing data insights and support for research and marketing initiatives. With a persistent focus on innovation and adaptability, Veradigm not only strengthens its foundational business in healthcare IT but also taps into new opportunities within the emerging landscape of digital health and data analytics.
See Also
What is Veradigm Inc's Other Current Assets?
Other Current Assets
57.3m
USD
Based on the financial report for Dec 31, 2022, Veradigm Inc's Other Current Assets amounts to 57.3m USD.
What is Veradigm Inc's Other Current Assets growth rate?
Other Current Assets CAGR 10Y
-10%
Over the last year, the Other Current Assets growth was -95%. The average annual Other Current Assets growth rates for Veradigm Inc have been -28% over the past three years , -25% over the past five years , and -10% over the past ten years .